|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07J 9/00 | (2006.01) |
| A61K 31/575 | (2006.01) | ||
| A61P 1/16 | (2006.01) |
| (11) | Number of the document | 2646457 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11788533.5 |
| Date of filing the European patent application | 2011-11-30 | |
| (97) | Date of publication of the European application | 2013-10-09 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-17 |
| (46) | Date of publication of the claims translation | 2016-10-10 |
| (86) | Number | PCT/EP2011/071406 |
| Date | 2011-11-30 |
| (87) | Number | WO 2012/072689 |
| Date | 2012-06-07 |
| (30) | Number | Date | Country code |
| 10193143 | 2010-11-30 | EP |
| (72) |
WILHELM, Rudolf, DE
PRÖLS, Markus, DE
FISCHER, Erik, DK
WAENERLUND POULSEN, Heidi, DK
|
| (73) |
Dr. Falk Pharma GmbH,
Leinenweberstrasse 5, 79108 Freiburg,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Grynų nepolimorfinių kristalinių, turinčių apibrėžtą dalelių dydį, tulžies rūgščių optimizuota sintezė |
| OPTIMIZED SYNTHESIS OF PURE, NON-POLYMORPHIC, CRYSTALLINE BILE ACIDS WITH DEFINED PARTICLE SIZE |
| Payment date | Validity (years) | Amount | |
| 2024-11-14 | 14 | 289.00 EUR |
| 2025-11-30 |